BioNexus Gene Lab Corp
Develops non-invasive, blood-based RNA tests for early cancer detection and risk assessment.
BGLC | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 10-2 TOWER B, VERTICAL BUSINESS SUITE,, 59200 KUALA LUMPUR
- Website:
- https://www.bionexusgenelab.com/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
BioNexus Gene Lab Corp. is a biotechnology company specializing in precision diagnostics and gene-based technologies. The company focuses on the development and application of blood-based genomic screening for early disease detection. Its core offering is the BGS test, a non-invasive blood test that analyzes circulating RNA to assess an individual's risk for a panel of common cancers. Through state-of-the-art RNA research and strategic partnerships, BioNexus Gene Lab aims to advance liquid biopsy cancer monitoring and AI-based diagnostics.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all BioNexus Gene Lab Corp filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BioNexus Gene Lab Corp
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BioNexus Gene Lab Corp via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
